Katina Dorton, J.D. M.B.A., is a recognized and internationally experienced financial executive, corporate director and public company CFO. Ms. Dorton’s strategic insights, expert perspective and financial acumen are informed by earlier career experience as a Wall Street investment banker and corporate transactions attorney. Her industry expertise includes healthcare and life sciences, industrial services and financial services. She currently is CFO at NodThera, a private Boston-based company focused on the NLRP3 inflammasome.
Throughout her career, Ms. Dorton has advised executive leaders and boards of directors on capital markets, fund raising, mergers and acquisitions, and other strategic transactions, collectively valued at more than $50 billion. As CFO, she has built financial, legal and operational functions to support companies through aggressive growth and transition including IPO preparation. She has served on several public company boards and has demonstrated strong leadership as Lead Director, Audit Chair and Governance Committee Chair. She meets the qualifications of an SEC financial expert, is a National Association of Corporate Directors (NACD) Corporate Governance Fellow, and serves on the NACD Lead Director Steering Committee. Ms. Dorton was named as one of Women Inc’s 2019 Most Influential Corporate Directors.